Sai Parenteral's Lists at 2% Premium - Should You Buy, Sell or Hold?

[{ "selector": ".alusb-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateX(calc(360px - 291px)) scale(0.15)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateX(0px) scale(1)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".txcot-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "opacity": 0, "visibility" :"visible"}, {"offset": 1, "opacity": "1", "visibility" :"visible"} ] }]

Listing Day Debut Sai

Parenteral's shares listed on NSE and BSE on April 2, 2026, at a modest 2% premium over its IPO price of ₹392.

[{ "selector": ".esntd-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-15px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".drnip-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(calc(600px - 550px))", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }]

IPO at a Glance

The ₹408.79 crore IPO opened March 24–27, 2026. Price band was ₹372–₹392, lot size 38 shares, minimum investment ₹14,896.

[{ "selector": ".wricq-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-15px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".uxmzk-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(calc(600px - 550px))", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }]

Subscription Numbers

The IPO was subscribed 1.05 times overall. NIIs led at 2.36x, QIBs at 1.71x, while retail participation was subdued at just 12%.

[{ "selector": ".ezoio-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-15px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".sljqk-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(calc(600px - 550px))", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }]

About Sai Parenteral's

Founded in 2001, it is a diversified pharma company offering branded generics and CDMO services across cardiovascular, anti-diabetic, respiratory, and dermatology segments.

[{ "selector": ".qpulf-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-15px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".gssxa-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(calc(600px - 550px))", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }]

With Our Subscription Plans

[{ "selector": ".mlrwk-a", "duration": "500ms", "fill": "forwards", "delay": "0ms", "keyframes": [ {"offset": 0, "opacity": 0, "visibility" :"visible"}, {"offset": 1, "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".nwwre-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "opacity": 0, "visibility" :"visible"}, {"offset": 1, "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".pqrdn-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateX(-299px)", "opacity": "1", "visibility" :"visible" }, {"offset": 1, "transform": "translateX(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".dring-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-33px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }] Open Demat A/C

Sai Parenteral's Lists at 2% Premium - Should You Buy, Sell or Hold?

Listing Day Debut Sai Parenteral's shares listed on NSE and BSE on April 2, 2026, at a modest 2% premium over its IPO price of ₹392.

IPO at a Glance The ₹408.79 crore IPO opened March 24–27, 2026. Price band was ₹372–₹392, lot size 38 shares, minimum investment ₹14,896.

Subscription Numbers The IPO was subscribed 1.05 times overall. NIIs led at 2.36x, QIBs at 1.71x, while retail participation was subdued at just 12%.

About Sai Parenteral's Founded in 2001, it is a diversified pharma company offering branded generics and CDMO services across cardiovascular, anti-diabetic, respiratory, and dermatology segments.

With Our Subscription Plans

Open demat account in 5 minutes*

Listing Day Debut Sai

Parenteral's shares listed on NSE and BSE on April 2, 2026, at a modest 2% premium over its IPO price of ₹392.

IPO at a Glance

The ₹408.79 crore IPO opened March 24–27, 2026. Price band was ₹372–₹392, lot size 38 shares, minimum investment ₹14,896.

Subscription Numbers

The IPO was subscribed 1.05 times overall. NIIs led at 2.36x, QIBs at 1.71x, while retail participation was subdued at just 12%.

About Sai Parenteral's

Founded in 2001, it is a diversified pharma company offering branded generics and CDMO services across cardiovascular, anti-diabetic, respiratory, and dermatology segments.